Roivant Sciences

Roivant Sciences

Developing transformative medicines faster by building technologies and developing talent in creative ways. Learn more

Launch date
Employees
Market cap
$9.0b
Enterprise valuation
$3.7b (Public information from Sep 2024)
Company register number CHE-289.087.624
New York City New York (HQ), Basel Canton of Basel-Stadt (founding location)
No columns specified